Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
Pre-Market: 20:00
Viatris Shareholders Equity (Quarterly): 19.79B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 19.79B |
June 30, 2024 | 19.52B |
March 31, 2024 | 20.01B |
December 31, 2023 | 20.47B |
September 30, 2023 | 20.87B |
June 30, 2023 | 20.84B |
March 31, 2023 | 20.93B |
December 31, 2022 | 21.07B |
September 30, 2022 | 19.18B |
June 30, 2022 | 19.81B |
March 31, 2022 | 20.45B |
December 31, 2021 | 20.49B |
September 30, 2021 | 21.14B |
June 30, 2021 | 21.21B |
March 31, 2021 | 21.41B |
December 31, 2020 | 22.95B |
September 30, 2020 | 12.55B |
June 30, 2020 | 11.75B |
March 31, 2020 | 11.26B |
December 31, 2019 | 11.88B |
September 30, 2019 | 11.46B |
June 30, 2019 | 11.90B |
March 31, 2019 | 11.89B |
December 31, 2018 | 12.17B |
September 30, 2018 | 12.07B |
Date | Value |
---|---|
June 30, 2018 | 12.21B |
March 31, 2018 | 13.18B |
December 31, 2017 | 13.31B |
September 30, 2017 | 13.29B |
June 30, 2017 | 12.83B |
March 31, 2017 | 11.66B |
December 31, 2016 | 11.12B |
September 30, 2016 | 11.83B |
June 30, 2016 | 10.33B |
March 31, 2016 | 10.27B |
December 31, 2015 | 9.764B |
September 30, 2015 | 9.814B |
June 30, 2015 | 9.568B |
March 31, 2015 | 9.073B |
December 31, 2014 | 3.256B |
September 30, 2014 | 3.388B |
June 30, 2014 | 3.334B |
March 31, 2014 | 3.174B |
December 31, 2013 | 2.942B |
September 30, 2013 | 3.215B |
June 30, 2013 | 2.929B |
March 31, 2013 | 2.871B |
December 31, 2012 | 3.341B |
September 30, 2012 | 3.609B |
June 30, 2012 | 3.185B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.26B
Minimum
Mar 2020
22.95B
Maximum
Dec 2020
18.88B
Average
20.46B
Median
Shareholders Equity (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | 178.51M |
Moderna Inc | 11.93B |
Baxter International Inc | 7.872B |
Gilead Sciences Inc | 18.47B |
Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 44.75B |
Total Liabilities (Quarterly) | 24.96B |
Debt to Equity Ratio | 0.7958 |
Current Ratio | 1.505 |
Net Debt Paydown Yield | 4.12% |